Correlation Between Enveric Biosciences and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Caribou Biosciences, you can compare the effects of market volatilities on Enveric Biosciences and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Caribou Biosciences.
Diversification Opportunities for Enveric Biosciences and Caribou Biosciences
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enveric and Caribou is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Caribou Biosciences
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Caribou Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Enveric Biosciences is 1.01 times less risky than Caribou Biosciences. The stock trades about -0.12 of its potential returns per unit of risk. The Caribou Biosciences is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 198.00 in Caribou Biosciences on September 1, 2024 and sell it today you would earn a total of 21.00 from holding Caribou Biosciences or generate 10.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enveric Biosciences vs. Caribou Biosciences
Performance |
Timeline |
Enveric Biosciences |
Caribou Biosciences |
Enveric Biosciences and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enveric Biosciences and Caribou Biosciences
The main advantage of trading using opposite Enveric Biosciences and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |